iShares Biotechnology ETF (IBB)


Market Price (9/2/2026): $213.8

iShares Biotechnology ETF (IBB)


Market Price (9/2/2026): $213.8

Key Takeaways

  • IBB has returned +25.0% YTD vs +12.0% for SPY; +52.9% over the past 12 months (SPY +19.1%). details →
  • Priced in gold, IBB has returned -29.2% over the past 3 years, vs +63.5% in dollars — its dollar gains have lagged gold. details →
  • Over the past month, IBB has seen net inflows of +$178M (+1.8% of assets). details →
  • 55% of IBB's portfolio (by weight) is currently profitable, vs 98% for SPY. details →
  • Risk-adjusted returns trail SPY: 3-year Sharpe ratio of 0.7 vs 1.0. details →
Last updated: 9/1/2026.

Price Chart

Asset Allocation with IBB

Risk Tolerance:
ConservativeModerateAggressive
Moderate — 55% equity / 25% bonds / 20% alternatives
10Y Return (ann.)
+7.9%
Volatility
12.7%
Sharpe
0.44
YTD
+15.7%
Modeled with monthly rebalancing to target weights; 10-year figures are annualized from monthly returns. Illustrative only — past performance is not indicative of future results.

Learn More →
Tailored Asset Allocation
[1] Personalized 5 Level Risk Tolerance Assessment
[2] Asset Allocation for My Risk Tolerance
Learn More →
Protect Wealth
[1] Defensive Portfolios
[2] Tax-Efficient Strategies

Valuation & Yield

 Forward [4,5]NowHistorical (CYE & TTM)
 9/30/279/2/2620252024202320222021
Share Price CYE $210.82$168.65$131.78$135.03$130.14$150.78
Dividend/Share TTM $0.39$0.39$0.39$0.35$0.41$0.32

Valuation [1]
       
P/S6.617.546.645.706.266.157.58
P/E 27.1522.9627.4825.4517.9216.09
P/E (Non-GAAP) [2]28.0537.1527.5430.0659.3922.1526.53
P/FCF 58.9366.91190.4086.8337.81

Yields TTM
       
Earnings Yield3.56%3.68%4.36%3.64%3.93%5.58%6.22%
Dividend Yield0.18%0.18%0.23%0.30%0.26%0.31%0.21%
Total Yield (TY)3.75%3.87%4.59%3.93%4.19%5.89%6.43%

Risk Premium [3]
       
Risk Free Rate (Rf)4.75%4.75%4.18%4.58%3.88%3.88%1.52%
Risk Prem. (TY - Rf)-1.00%-0.88%0.41%-0.65%0.31%2.01%4.91%

Growth Rates [6]
       
Sales Growth10.9%5.5%11.7%7.8%-3.9%2.0% 
Earnings Growth [7] -114.1%  -184.3%-81.7% 

[1] P/E uses the aggregate method over profitable constituents; P/FCF aggregates net free cash flow across all constituents (negative-FCF names reduce it); P/S uses all constituents. Ratios reflect current ETF holdings at current weights. P/FCF has no Forward column (no analyst FCF estimate).
[2] P/E (Non-GAAP) uses analyst consensus net income (adjusted basis) for all periods. The standard P/E row above uses GAAP net income.
[3] The premium above the risk free rate (US 10Y) offered by the investment. Negative premiums can indicate stretched valuations.
Show more
[4] Forward P/S and Forward P/E determined as:
  (a) Aggregate using constituent analyst consensus. FY1/FY2 blended by months of overlap to the 12-month window ending 9/30/27.
  (b) Uses current weights and market caps. Shown only when ≥90% of weight has estimates.
[5] Forward dividend yield and risk-free rate are carried at current, not projected.
[6] Growth Rates:
  (a) Weighted by current constituent weights. Shown when ≥90% of weight is covered.
  (b) Now and Historical columns show realized year-over-year change.
  (c) Forward growth rates using next fiscal year (FY2) vs. current fiscal year (FY1) consensus. This differs from the blended target date used for calculating Forward P/S and P/E.
[7] Earnings Growth reflects:
  (a) Non-GAAP earnings growth for forward earnings using next fiscal year (FY2) vs. current fiscal year (FY1) consensus.
  (b) GAAP earnings growth for Now and Historical growth rates.

Highlights
YIELD
IBB's earnings yield is 3.68%, based on its 27.2x trailing P/E. With a 0.18% dividend yield, IBB is yielding 3.87% in total.
RISK
Compared to US Treasuries at 4.75%, IBB's total yield implies a -0.88% risk premium. A negative risk premium means investors earn less than risk-free Treasuries — valuations are historically stretched, though expectations of falling interest rates or fast earnings growth can justify such levels.
FORWARD EXPECTATIONS
Based on analyst estimates, IBB's forward total yield is 3.75%, implying a -1.00% risk premium assuming stable Treasury rates.

Top 20 Holdings for IBB

Total Weights
Top 5: 33.2% | Top 10: 47.4% | Top 20: 62.4%

TickerHoldingETF WeightSales WeightEarnings WeightFwd P/SFwd P/EFwd Sales GrowthFwd Earnings Growth
Total76.54%100.00%100.00%6.427.9+10.9%+17.2%
Top 2051.44%69.29%81.37%6.423.6+9.0%+19.1%
AMGNAmgen8.53%13.15%19.90%5.918.2+3.4%+5.4%
VRTXVertex Pharmaceuticals8.04%6.97%16.10%9.825.6+10.2%+15.6%
GILDGilead Sciences7.20%11.26%5.820.5+6.5%
REGNRegeneron Pharmaceuticals5.70%10.01%18.40%4.713.3+9.0%+12.6%
ARGXargenx3.78%
MRNAModerna3.57%1.23%26.4+14.3%
NTRANatera3.17%1.79%13.8+19.7%
RVMDRevolution Medicines2.82%
ILMNIllumina2.31%3.18%3.86%6.534.5+6.0%+14.1%
BIIBBiogen2.27%6.84%3.76%3.013.9+2.1%+33.4%
ALNYAlnylam Pharmaceuticals2.24%3.14%3.48%5.028.0+26.9%+39.3%
ONCBeOne Medicines2.08%
INSMInsmed1.81%0.75%10.1562.5+60.7%
INCYIncyte1.75%3.89%7.12%4.115.9+5.0%+160.5%
UTHRUnited Therapeutics1.50%2.08%5.70%6.516.2+9.4%+9.9%
ROIVRoivant Sciences1.27%0.00%111.7+670.6%
GMABGenmab1.23%
ASNDAscendis Pharma1.09%
NBIXNeurocrine Biosciences1.08%2.21%3.05%3.618.1+15.4%+39.8%
CRLCharles River Laboratories International0.99%2.79%3.422.6+2.1%+11.8%
[1] Total and Top 20 rows are weighted aggregates across constituents.
[2] Forward P/S and P/E ratios use consensus sales and earnings for the 12 months ending 9/30/27. Individual constituent FY1 and FY2 consensus figures adjusted to align with 9/30/27.
[3] Forward Sales and Non-GAAP Earnings Growth are calculated as next fiscal year (FY2) consensus growth over current fiscal year (FY1) consensus. They are not derived from the forward P/S and P/E multiples shown.

Performance for IBB Top Holdings

TickerHoldingWeightMkt Price
9/1
1D Rtn1M RtnYTD Rtn1Y Rtn3Y Rtn5Y Rtn10Y Rtn
IBBiShares Biotechnology ETF100.00%210.820.8%13.1%25.0%52.9%63.5%21.4%130.9%
AMGNAmgen8.53%438.121.9%14.4%36.6%56.5%86.7%126.5%250.4%
VRTXVertex Pharmaceuticals8.04%547.650.6%14.8%20.8%40.1%56.0%174.9%475.8%
GILDGilead Sciences7.20%149.922.4%15.1%23.6%36.2%115.9%148.7%177.8%
REGNRegeneron Pharmaceuticals5.70%823.823.1%8.1%7.1%42.6%-0.0%23.1%114.0%
ARGXargenx3.78%1,028.51-0.3%20.5%22.3%44.4%99.8%194.6% 
MRNAModerna3.57%154.279.9%181.4%423.1%540.4%37.1%-61.2% 
NTRANatera3.17%320.76-0.4%19.8%40.0%90.6%413.1%159.6%3,041.6%
RVMDRevolution Medicines2.82%209.872.1%11.9%163.5%452.7%498.8%603.8% 
ILMNIllumina2.31%207.13-3.0%1.0%57.9%107.2%26.5%-54.6%26.9%
BIIBBiogen2.27%216.04-0.3%6.4%22.8%63.4%-19.1%-35.6%-25.2%
ALNYAlnylam Pharmaceuticals2.24%246.112.3%19.7%-38.1%-44.9%22.3%22.9%255.8%
ONCBeOne Medicines2.08%358.65-0.3%13.5%18.1%17.2%71.7%7.7%1,116.2%
INSMInsmed1.81%121.51-0.3%23.2%-30.2%-10.7%436.7%315.6%812.2%
INCYIncyte1.75%125.011.5%4.6%26.6%47.7%93.2%61.9%52.4%
UTHRUnited Therapeutics1.50%512.700.5%-1.0%5.2%68.2%124.8%141.5%317.1%
ROIVRoivant Sciences1.27%34.52-0.3%1.8%59.1%189.4%195.5%246.9% 
GMABGenmab1.23%33.290.4%15.3%8.1%33.9%-13.3%-31.7%109.7%
ASNDAscendis Pharma1.09%260.25-1.1%6.7%22.0%34.0%164.8%47.1%1,241.5%
NBIXNeurocrine Biosciences1.08%156.761.8%-6.0%10.5%12.3%41.7%62.8%217.1%
CRLCharles River Laboratories International0.99%282.34-2.0%21.4%41.5%72.9%34.7%-37.1%234.4%

Guidance Updates for IBB Top Holdings

 TickerCompanyEarnings DateGuidance MetricMidpoint Value% ChangeGuidance Change
ALNY_7302026ALNYAlnylam Pharmaceuticals7/30/20262026 Net revenues from collaborations and royalties600.00 Mil33.3%RaisedRaised Prior Guidance of 450.00 Mil for 2026
INCY_7282026INCYIncyte7/28/20262026 Total net sales5.20 Bil7.0%RaisedRaised Prior Guidance of 4.86 Bil for 2026
INSM_8062026INSMInsmed8/6/20262026 BRINSUPRI Revenue1.32 Bil32.5%RaisedRaised Prior Guidance of 1.00 Bil for 2026

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
IBB Return1%-14%4%-2%28%24%40%
Peers Return28%-8%33%14%34%43%244%
S&P 500 Return27%-19%24%23%16%12%105%

Monthly Win Rates [3]
IBB Win Rate42%50%58%58%58%62% 
Peers Win Rate62%48%57%55%68%70% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
IBB Max Drawdown-17%-31%-18%-12%-21%-10% 
Peers Max Drawdown-22%-38%-19%-20%-28%-20% 
S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: SMH, SOXX, XBI, ITA, XOP.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 9/1/2026 (YTD)

Sharpe Ratios Compared

One measure of reward vs. risk is a Sharpe ratio. A higher ratio indicates better risk-adjusted returns. Most funds have Sharpe ratios < 1.0.

Ticker1Y3Y5Y
IBB1.830.690.13
Equity Top Results (3Y)   
IALT2.082.082.08
VLUE2.531.420.74
SPMO0.941.370.79
CORO1.351.331.33
CGDV1.281.310.94

Results as of 8312026.

How Low Can It Go

EventIBBS&P 500
2025 US Tariff Shock
  % Loss-19.2%-18.8%
  % Gain to Breakeven23.7%23.1%
  Time to Breakeven129 days79 days
Summer-Fall 2023 Five Percent Yield Shock
  % Loss-12.8%-9.5%
  % Gain to Breakeven14.7%10.5%
  Time to Breakeven47 days24 days
2022 Inflation Shock & Fed Tightening
  % Loss-30.5%-24.5%
  % Gain to Breakeven43.8%32.4%
  Time to Breakeven1205 days427 days
2020 COVID-19 Crash
  % Loss-23.6%-33.7%
  % Gain to Breakeven30.8%50.9%
  Time to Breakeven32 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-26.1%-19.2%
  % Gain to Breakeven35.3%23.8%
  Time to Breakeven357 days105 days
2016-2017 Trump Reflation Bond Selloff
  % Loss-16.3%-3.7%
  % Gain to Breakeven19.5%3.9%
  Time to Breakeven116 days6 days

Compare to SMH, SOXX, XBI, ITA, XOP

In The Past

iShares Biotechnology ETF's stock fell -19.2% during the 2025 US Tariff Shock. Such a loss loss requires a 23.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

EventIBBS&P 500
2022 Inflation Shock & Fed Tightening
  % Loss-30.5%-24.5%
  % Gain to Breakeven43.8%32.4%
  Time to Breakeven1205 days427 days
2020 COVID-19 Crash
  % Loss-23.6%-33.7%
  % Gain to Breakeven30.8%50.9%
  Time to Breakeven32 days140 days
Q4 2018 Fed Policy Error / Growth Scare
  % Loss-26.1%-19.2%
  % Gain to Breakeven35.3%23.8%
  Time to Breakeven357 days105 days
2015-2016 China Devaluation / Global Growth Scare
  % Loss-34.3%-12.2%
  % Gain to Breakeven52.3%13.9%
  Time to Breakeven1411 days62 days
2011 US Debt Ceiling Crisis & European Contagion
  % Loss-22.3%-17.9%
  % Gain to Breakeven28.7%21.8%
  Time to Breakeven155 days123 days
2008-2009 Global Financial Crisis
  % Loss-29.3%-53.4%
  % Gain to Breakeven41.5%114.4%
  Time to Breakeven196 days1085 days

Compare to SMH, SOXX, XBI, ITA, XOP

In The Past

iShares Biotechnology ETF's stock fell -19.2% during the 2025 US Tariff Shock. Such a loss loss requires a 23.7% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

IBB Dip Buy History


Get Notified
Alerts when dip buy opportunities arise.
Notify Me →

Current Dip Buy Opportunities Across ETFs

ETFs currently down 5% or more from trailing 6M peaks.

TickerNameDip %Mkt PricePrice DatePeak PricePeak Date# Days
QQQInvesco QQQ Trust, Series 1-5.2%707.649012026746.16602202691
QQQMInvesco NASDAQ 100 ETF-5.2%291.409012026307.23602202691
IJHiShares Core S&P Mid-Cap ETF-5.2%74.60901202678.67816202616
MDYState Street SPDR S&P MIDCAP 400 ETF Trust-5.2%679.959012026716.91816202616
IVOOVanguard S&P Mid-Cap 400 ETF-5.1%126.259012026133.08816202616
SCHASchwab U.S. Small-Cap ETF-6.6%33.73901202636.13630202663
IWFiShares Russell 1000 Growth ETF-5.9%121.219012026128.77601202692
VONGVanguard Russell 1000 Growth ETF-5.7%124.819012026132.35601202692
IWPiShares Russell Mid-Cap Growth ETF-6.6%137.929012026147.70817202615
VOTVanguard Mid-Cap Growth ETF-5.5%296.669012026314.02816202616
IJKiShares S&P Mid-Cap 400 Growth ETF-6.2%111.679012026119.11817202615
MDYGState Street SPDR S&P 400 Mid Cap Growth ETF-6.2%106.639012026113.69817202615
IWOiShares Russell 2000 Growth ETF-6.1%371.419012026395.65816202616
VBKVanguard Small-Cap Growth ETF-5.9%344.639012026366.24817202615
IJTiShares S&P Small-Cap 600 Growth ETF-6.4%167.689012026179.07804202628
SLYGState Street SPDR S&P 600 Small Cap Growth ETF-6.3%111.949012026119.50804202628
IEMGiShares Core MSCI Emerging Markets ETF-5.3%81.43901202686.00622202671
EEMiShares MSCI Emerging Markets ETF-6.2%66.77901202671.21622202671
ASHRXtrackers Harvest CSI 300 China A-Shares ETF-8.3%34.21901202637.30622202671
EWYiShares MSCI South Korea ETF-19.8%175.809012026219.20621202672
EWZiShares MSCI Brazil ETF-12.4%36.57901202641.734142026140
FXIiShares China Large-Cap ETF-7.6%35.34901202638.265132026111
ILFiShares Latin America 40 ETF-8.0%35.06901202638.104142026140
KWEBKraneShares CSI China Internet ETF-17.1%25.69901202630.993102026175
MTUMiShares MSCI USA Momentum Factor ETF-14.1%296.529012026345.22622202671
SPHQInvesco S&P 500 Quality ETF-6.2%84.50901202690.10630202663
SPMOInvesco S&P 500 Momentum ETF-10.0%145.549012026161.66622202671
URAGlobal X Uranium ETF-24.6%43.94901202658.265062026118
BOTZGlobal X Funds Global X Robotics & Artificial Intelligence ETF-15.6%35.15901202641.635132026111
ROBOROBO Global Robotics & Automation Index ETF-12.7%78.87901202690.34602202691
LITGlobal X Lithium & Battery Tech ETF-18.5%74.71901202691.625112026113
ICLNiShares Global Clean Energy ETF-27.4%17.24901202623.75602202691
ARKQARK Autonomous Technology & Robotics ETF-16.5%120.159012026143.82528202696
ARKXARK Space & Defense Innovation ETF-15.7%31.83901202637.74528202696
NASATema Space Innovators ETF-45.9%22.68901202641.89527202697
AGIXKraneShares Artificial Intelligence ETF-10.5%44.20901202649.40601202692
DRSKAptus Defined Risk ETF-5.1%28.16901202629.67601202692
GDEWisdomTree Efficient Gold Plus Equity Strategy Fund-7.2%66.17901202671.3082520267
VGTVanguard Information Technology ETF-5.4%118.879012026125.62602202691
XLKState Street Technology Select Sector SPDR ETF-7.4%183.649012026198.21602202691
XLIState Street Industrial Select Sector SPDR ETF-7.4%172.739012026186.51816202616
XLCState Street Communication Services Select Sector SPDR ETF-6.9%110.889012026119.104192026135
XLYState Street Consumer Discretionary Select Sector SPDR ETF-6.1%114.599012026122.06528202696
XLUState Street Utilities Select Sector SPDR ETF-9.7%42.56901202647.154092026145
IYJiShares U.S. Industrials ETF-6.6%158.719012026169.86804202628
SMHVanEck Semiconductor ETF-18.5%545.229012026668.91622202671
SOXXiShares Semiconductor ETF-23.6%500.319012026655.01622202671
ITAiShares U.S. Aerospace & Defense ETF-11.0%225.469012026253.22816202616
IYTiShares U.S. Transportation ETF-7.9%82.93901202690.01716202647
KREState Street SPDR S&P Regional Banking ETF-6.8%72.62901202677.93816202616
MISLFirst Trust Indxx Aerospace & Defense ETF-13.7%43.49901202650.393042026181
RINGiShares MSCI Global Gold Miners ETF-10.8%83.12901202693.1782520267
SOXQInvesco PHLX Semiconductor ETF-22.8%88.909012026115.11622202671
TLTiShares 20+ Year Treasury Bond ETF-6.7%81.87901202687.723032026182
VGLTVanguard Long-Term Treasury ETF-5.6%52.56901202655.693032026182
SPTLState Street SPDR Portfolio Long Term Treasury ETF-6.0%25.01901202626.603032026182
TLHiShares 10-20 Year Treasury Bond ETF-5.3%96.239012026101.623032026182
EDVVanguard World Funds Extended Duration ETF-9.7%59.89901202666.313032026182
SPLBState Street SPDR Portfolio Long Term Corporate Bond ETF-5.2%21.23901202622.40629202664
GSGiShares GSCI Commodity-5.8%30.01901202631.853182026167
GLDSPDR Gold Trust-17.0%396.759012026477.863102026175
IAUiShares Gold Trust-16.9%81.35901202697.853102026175
GLDMSPDR Gold MiniShares Trust-16.8%85.599012026102.893102026175
SGOLETFS Physical Swiss Gold Shares-9.8%44.66901202649.533102026175
BARDirexion Daily Gold Bull 3X Shares-13.4%44.34901202651.203102026175
SLViShares Silver Trust-27.7%57.92901202680.093102026175
PPLTETFS Physical Platinum Shares-21.0%15.80901202620.003102026175
CPERUnited States Copper Index Fund ETV-7.7%33.33901202636.123112026174
PALLETFS Physical Palladium Shares-22.7%23.68901202630.643092026176
USOUnited States Oil Fund LP-7.8%141.009012026152.965192026105
UNGUnited States Natural Gas Fund LP-18.9%10.58901202613.043122026173
BNOUnited States Brent Oil Fund LP ETV-7.1%55.85901202660.135042026120
SCHHSchwab U.S. REIT ETF-5.1%23.58901202624.86726202637
REETiShares Global REIT ETF-5.1%27.43901202628.89726202637
USRTiShares Core U.S. REIT ETF-6.0%65.60901202669.82726202637
IBITiShares Bitcoin Trust ETF-5.8%43.76901202646.475112026113
FBTCFidelity Wise Origin Bitcoin Fund-5.8%67.18901202671.355112026113

ETF Fund Flows

Largest fund inflows and outflows across ETFs, with the asset-allocation rotation they imply.

Net fund flows · as of 2026-09-01

Asset allocation rotation · Past month

  • Equity ETFs drew the largest net inflows (+$45.4B), followed by Bond (+$20.8B), while Real Estate (−$162M) saw the largest outflows.
  • Within the mix, money rotated into US Nasdaq Growth (+$15.3B) and out of Intermediate Treasury (−$8.7B).
  • Relative to fund size, CNEQ drew the largest inflow (+96.5% of AUM) and TAN the largest outflow (−20.2%).
Largest inflows
#TickerNameTypeNet flow% of AUM
1VOOVanguard S&P 500 ETFEquity US Large Cap Core+$24.31B+2.3%
2QQQInvesco QQQ Trust, Series 1Equity US Nasdaq Growth+$12.08B+2.5%
3SGOViShares 0-3 Month Treasury Bond ETFCash+$7.92B+7.6%
4GLDSPDR Gold SharesCommodity Gold+$5.56B+3.8%
5VTIVanguard Morningstar Total Stock Market ETFEquity US Total Market+$5.37B+0.8%
6TLTiShares 20+ Year Treasury Bond ETFBond Long Treasury+$5.28B+11.5%
7VGSHVanguard Short-Term Treasury ETFBond Short Treasury+$4.58B+15.0%
8SCHDSchwab U.S. Dividend Equity ETFEquity Dividend Income+$3.74B+3.4%
9AVLVAvantis U.S. Large Cap Value ETFOther+$3.4B+17.9%
10QQQMInvesco NASDAQ 100 ETFEquity US Nasdaq Growth+$3.22B+3.1%
Largest outflows
#TickerNameTypeNet flow% of AUM
1IVViShares Core S&P 500 ETFEquity US Large Cap Core-$13.5B-1.5%
2IEFiShares 7-10 Year Treasury Bond ETFBond Intermediate Treasury-$4.83B-11.2%
3XLFState Street Financial Select Sector SPDR ETFEquity Broad Sector-$4.47B-7.9%
4SPYState Street SPDR S&P 500 ETFEquity US Large Cap Core-$3.41B-0.4%
5SOXXiShares Semiconductor ETFEquity Industry Subsector-$3.34B-7.8%
6VGITVanguard Intermediate-Term Treasury ETFBond Intermediate Treasury-$2.46B-5.8%
7SMHVanEck Semiconductor ETFEquity Industry Subsector-$1.82B-2.6%
8GOVTiShares U.S. Treasury Bond ETFBond Intermediate Treasury-$1.78B-4.1%
9HYGiShares iBoxx $ High Yield Corporate Bond ETFBond High Yield Corporate-$1.44B-8.1%
10XLKState Street Technology Select Sector SPDR ETFEquity Broad Sector-$1.28B-1.1%

Largest ETF fund flows across ~2625 funds (min AUM $100M). Net creations/redemptions; leveraged & inverse ETFs excluded. A ⚠ marks a day excluded as a suspected data error.

Set Alerts and Notifications

Stay Informed

Trade & Investment Ideas

Wealth

Alert Me Periodically

Inform Me Once

About IBB

0Holdings Count: 247
Expense Ratio: 0.44%
Inception Date: 2001-02-04
iShares Biotechnology ETF
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Asset Class: Equity | ETF Website

Recent Active Movers

Peer Comparisons

Peers to compare with:

Profile

IBBSMHSOXXXBIITAXOPMedian
NameiShares Bi.VanEck Sem.iShares Se.State Stre.iShares U..State Stre. 
Asset ClassEquityEquityEquityEquityEquityEquity-
AUM ($ Bil)10.567.641.712.013.93.913.0
Expense Ratio0.44%0.35%0.33%0.35%0.37%0.35%0.35%
10-D Avg Volume (Mil)1.5510.739.588.750.783.446.10
Latest Day Volume (Mil)0.292.033.341.16-0.251.16
Holdings Count2472630155485150
Inception Date2/4/200112/20/20117/9/20011/31/20064/30/20066/19/2006-

Fundamentals

IBBSMHSOXXXBIITAXOPMedian
NameiShares Bi.VanEck Sem.iShares Se.State Stre.iShares U..State Stre. 
Net Asset Value208.98553.12508.44168.23232.77185.42-
Premium/Discount0.9%-1.4%-1.6%-2.9%-3.1%3.9%-1.5%
Distribution Yield0.2%0.2%0.3%0.3%0.0%1.7%0.2%
Sales Yield12.0%7.8%8.2%8.2%31.4%114.4%10.1%
Earnings Yield1.8%2.6%2.3%1.2%2.8%7.5%2.4%

Valuation

IBBSMHSOXXXBIITAXOPMedian
NameiShares Bi.VanEck Sem.iShares Se.State Stre.iShares U..State Stre. 
P/S (TTM)8.4x12.8x12.2x12.2x3.2x0.9x10.3x
P/E (TTM)55.2x38.7x43.8x81.2x36.3x13.4x41.2x
P/FCF (TTM)-46.7x51.1x-38.3x16.3x42.5x
Forward P/E---64.4x29.7x11.2x29.7x
Forward P/S---8.0x2.9x0.8x2.9x

Risk

IBBSMHSOXXXBIITAXOPMedian
NameiShares Bi.VanEck Sem.iShares Se.State Stre.iShares U..State Stre. 
Volatility (1Y)21.8%39.3%45.3%28.0%23.2%29.1%28.6%
Volatility (3Y)20.9%36.8%39.4%27.9%20.1%28.2%28.1%
Volatility (5Y)22.2%36.6%38.4%32.3%20.3%33.3%32.8%
Beta (1Y)0.772.382.591.051.03-0.331.04
Beta (3Y)0.821.972.051.030.850.660.94
Beta (5Y)0.861.761.811.160.810.851.01
Sharpe Ratio (1Y)2.051.811.812.290.681.481.81
Sharpe Ratio (3Y)0.921.371.171.021.260.551.09
Sharpe Ratio (5Y)0.310.970.830.320.880.770.80
Max Drawdown (1Y)-9.6%-24.6%-29.0%-10.5%-15.8%-18.7%-17.3%
Max Drawdown (3Y)-24.9%-35.7%-41.4%-33.0%-15.8%-35.0%-34.0%
Max Drawdown (5Y)-39.7%-45.3%-45.8%-54.0%-18.7%-35.0%-42.5%

Returns

IBBSMHSOXXXBIITAXOPMedian
NameiShares Bi.VanEck Sem.iShares Se.State Stre.iShares U..State Stre. 
1M Return13.4%-0.0%-1.5%10.9%-8.4%10.6%5.3%
3M Return28.3%-13.8%-17.3%27.9%-1.3%14.1%6.4%
6M Return24.0%39.4%49.5%32.3%-7.9%21.7%28.2%
YTD Return25.0%51.4%66.2%34.0%5.1%53.3%42.7%
1Y Return52.9%88.4%104.8%82.5%14.1%47.5%67.7%
2Y Return43.3%124.2%120.0%62.3%57.5%45.4%59.9%
3Y Return66.6%270.7%215.1%108.8%101.9%41.0%105.3%

Short Interest

Short Interest: As Of Date8142026
Short Interest: Shares Quantity10.4 Mil
Short Interest: % Change Since 73120264.0%
Average Daily Volume1.4 Mil
Days-to-Cover Short Interest7.4 days